95 related articles for article (PubMed ID: 14749527)
1. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases.
Jung HW; La SJ; Kim JY; Heo SK; Kim JY; Wang S; Kim KK; Lee KM; Cho HR; Lee HW; Kwon B; Kim BS; Kwon BS
Exp Mol Med; 2003 Dec; 35(6):501-8. PubMed ID: 14749527
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
[TBL] [Abstract][Full Text] [Related]
3. LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM.
Heo SK; Ju SA; Lee SC; Park SM; Choe SY; Kwon B; Kwon BS; Kim BS
J Leukoc Biol; 2006 Feb; 79(2):330-8. PubMed ID: 16275888
[TBL] [Abstract][Full Text] [Related]
4. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation.
La S; Kim J; Kwon BS; Kwon B
Mol Cells; 2002 Dec; 14(3):398-403. PubMed ID: 12521303
[TBL] [Abstract][Full Text] [Related]
6. Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator.
Ono E; Yoshino S; Amagai K; Taharaguchi S; Kimura C; Morimoto J; Inobe M; Uenishi T; Uede T
Virology; 2004 Mar; 320(2):267-75. PubMed ID: 15016549
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
8. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
[TBL] [Abstract][Full Text] [Related]
9. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
Costello RT; Mallet F; Barbarat B; Schiano De Colella JM; Sainty D; Sweet RW; Truneh A; Olive D
Leukemia; 2003 Dec; 17(12):2500-7. PubMed ID: 14562115
[TBL] [Abstract][Full Text] [Related]
11. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells.
Cai G; Wang H; Qin Q; Zhang J; Zhu Z; Liu M; Shen Q
Cardiovasc Res; 2009 Dec; 84(3):425-33. PubMed ID: 19570810
[TBL] [Abstract][Full Text] [Related]
13. Balancing co-stimulation and inhibition with BTLA and HVEM.
Murphy KM; Nelson CA; Sedý JR
Nat Rev Immunol; 2006 Sep; 6(9):671-81. PubMed ID: 16932752
[TBL] [Abstract][Full Text] [Related]
14. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.
Warner MS; Geraghty RJ; Martinez WM; Montgomery RI; Whitbeck JC; Xu R; Eisenberg RJ; Cohen GH; Spear PG
Virology; 1998 Jun; 246(1):179-89. PubMed ID: 9657005
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft M
Nat Rev Immunol; 2003 Aug; 3(8):609-20. PubMed ID: 12974476
[TBL] [Abstract][Full Text] [Related]
17. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
18. The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
Zhao Q; Zhang GL; Zhu X; Su D; Huang ZL; Hu ZX; Peng L
J Gastroenterol Hepatol; 2017 Aug; 32(8):1520-1524. PubMed ID: 27987232
[TBL] [Abstract][Full Text] [Related]
19. The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients.
Heo SK; Ju SA; Kim GY; Park SM; Back SH; Park NH; Min YJ; An WG; Nguyen TT; Kim SM; Kim BS
Exp Mol Med; 2012 Feb; 44(2):149-58. PubMed ID: 22113134
[TBL] [Abstract][Full Text] [Related]
20. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]